Research Papers

25 of 2050 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Visual Ordinal Coronary Artery Calcium Score from Non-Gated Chest CT Predicts Mortality After Severe Chronic Obstructiv…
Xu H; Yew MS.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Early Diagnosis of High-Risk Chronic Obstructive Pulmonary Disease Based on Quantitative High-Resolution Computed Tomog…
Zhang W; Zhao Y; Tian Y; Liang X; Piao C.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
2/6 Transparent
Trend Analysis of Palliative Care Utilization in Patients with Chronic Obstructive Pulmonary Disease During Hospitaliza…
Kao LT; Ko SC; Chen PJ; Wu YC; Liao KM; Liang YS; Ho CH; Liang FW.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Lung Fibroblasts from Chronic Obstructive Pulmonary Disease Subjects Have a Deficient Gene Expression Response to Cigar…
Garcia-Ryde M; van der Burg NMD; Larsson CE; Larsson-Callerfelt AK; Westergren-Thorsson G; Bjermer L; Tufvesson E.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Airway and Systemic Immune Responses Following the Third COVID-19 Vaccination in COPD Patients.
Southworth T; Jackson N; Singh D.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Is Frailty a Mortality Predictor in Subjects with Chronic Obstructive Pulmonary Disease?
Nishimura K; Kusunose M; Shibayama A; Nakayasu K.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Utility of Cardiopulmonary Exercise Testing in Chronic Obstructive Pulmonary Disease: A Review.
Behnia M; Sietsema KE.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
2/6 Transparent
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A R…
Czira A; Akiyama S; Ishii T; Wood RP; Camidge LJ; Wallis H; Jennison T; Wild RAC; Yarita M; Hashimoto K; Rothnie KJ; Ismaila AS.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within…
Alter P; Stoleriu C; Kahnert K; Henke MO; Bals R; Trudzinski FC; Watz H; Speicher T; Söhler S; Welte T; Rabe KF; Wouters EFM; Vogelmeier CF; Jörres RA.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Characteristics of Serum Autoantibody Repertoire and Immune Subgroup Variation of Tuberculosis-Associated Obstructive P…
Jiang M; Pang N; Wang J; Li Z; Xu D; Jing J; Chen D; Li F; Ding J; Li Q.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Screening of potential key ferroptosis-related genes in Chronic Obstructive Pulmonary Disease.
Cao Y; Pan H; Yang Y; Zhou J; Zhang G.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment.
Turégano-Yedro M; Trillo-Calvo E; Navarro I Ros F; Maya-Viejo JD; González Villaescusa C; Echave Sustaeta JM; Doña E; Alcázar Navarrete B.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Physical Activity, Depression and Quality of Life in COPD - Results from the CLARA II Study.
Horner A; Olschewski H; Hartl S; Valipour A; Funk GC; Studnicka M; Merkle M; Kaiser B; Wallner EM; Brecht S; Lamprecht B.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Screening of Lipid Metabolism-Related Genes as Diagnostic Indicators in Chronic Obstructive Pulmonary Disease.
Jiang C; Peng M; Dai Z; Chen Q.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Clinical Characteristics and Medical Utilization of Smokers with Preserved Ratio Impaired Spirometry [Response to Lette…
Shin YY; Park S; Kim KJ; Rhee CK; Yoo KH; Jung KS; Lee JH.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
2/6 Transparent
Ambulatory Long-Term Oxygen Therapy in Patients with Severe COPD: A Randomized Crossover Trial to Compare Constant-Minu…
Majorski DS; Khan SG; Stanzel SB; Wollsching-Strobel M; Kroppen D; Mathes T; Zimmermann M; Windisch W; Magnet FS.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Blocking CD40 Alleviates Th1 and Th17 Cell Responses in Elastin Peptide-Induced Murine Emphysema.
Ma T; Zhang H; Weng Y; Tang S; Mao J; Feng X; Zhang Y; Zhang J.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
RETRO-POPE: A Retrospective, Multicenter, Real-World Study of All-Cause Mortality in COPD.
Koblizek V; Milenkovic B; Svoboda M; Kocianova J; Holub S; Zindr V; Ilic M; Jankovic J; Cupurdija V; Jarkovsky J; Popov B; Valipour A.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) - A Systematic Review.
Chow R; So OW; Im JHB; Chapman KR; Orchanian-Cheff A; Gershon AS; Wu R.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Registered
Exploring Patterns of COPD Exacerbations and Comorbid Flare-Ups.
van Dijk SHB; Brusse-Keizer MGJ; Effing T; van der Valk PDLPM; Ploumen EH; van der Palen J; Doggen CJM; Lenferink A.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
30-Day Readmission Rate of Patients with COPD and Its Associated Factors: A Retrospective Cohort Study from a Tertiary …
Kee YS; Wong CK; Abdul Aziz MA; Zakaria MI; Mohd Shaarif F; Ng KS; Liam CK; Pang YK; Khoo EM.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Factors Associated with Chronic Obstructive Pulmonary Disease: A Hospital-Based Case-Control Study.
Twinamasiko B; Mutekanga A; Ogueri O; Kisakye NI; North CM; Muzoora C; Muyanja D.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Knockdown of GNL3L Alleviates the Progression of COPD Through Inhibiting the ATM/p53 Pathway.
Cai Q; Chen S; Zhu Y; Li Z.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Representation of Females and Younger Adults in Studies Reporting Predictors of Readmission for Patients with Chronic O…
Im JHB; Chow R; So OW; Wu R; Gershon AS.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
2/6 Transparent
Predictors of Success of Inpatient Pulmonary Rehabilitation Program in COPD Patients.
Hafner T; Pirc Marolt T; Šelb J; Grošelj A; Kosten T; Simonič A; Košnik M; Korošec P.
Int J Chron Obstruct Pulmon Dis (Unknown)
Published: 2023
2/6 Transparent